A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid ...

EXCLUSIVE: UCL researchers argue that loss of brain volume may in fact be a sign that the treatments are working.

A loss of brain volume associated with new immunotherapies for Alzheimer's disease may be caused by the removal of amyloid plaques, rather than the loss of neurons or brain tissue, finds a new study.

Research reveals belly fat in midlife can shrink the brain’s memory center and show early signs of Alzheimer’s long before ...

"Amyloid immunotherapy has consistently shown an increase in brain volume loss – leading to concerns in the media and medical ...

Brain volume loss linked to new Alzheimer’s immunotherapies, such as lecanemab, is caused by the removal of amyloid plaques ...